Inhalation company Inhalation Sciences has entered into a conditional financing agreement for a credit facility of up to SEK 4 million with Tellus Equity, JEQ Capital and Thalor Capital. The financing is intended to strengthen liquidity while the company evaluates a possible strategic transaction and continues ongoing operations.The lenders are granted the right to convert the loan into shares and receive 8.8 million warrants. The agreement requires approval at an extraordinary general meeting on August 18. Upon full conversion and exercise of warrants, the maximum dilution amounts to approximately 30.6 percent.